6898-97-1 Usage
Description
Diethylstilbestrol is a derivative of stilbene, and it differs from sin-estrol by the presence
of a double bond with trans-configuration of the two phenyl groups. In terms of estrogenic
activity, this drug surpasses both estrone and hexestrol.
Chemical Properties
White solid
Uses
Diethylstilbestrol was used as internal standard for the analysis of drug residues in urine of rats and calves by on-line HPLC with ultraviolet and continuous-flow fast atom bombardmentmass spectrometry detectors.
General Description
Mechanisms of the isomerization processes of molecular and anionic diethylstilbestrol (DES) has been reported. Estrogen activity of cis- and trans-diethylstilbestrol has been evaluated. Diethylstilbestrol is a carcinogenic synthetic estrogen.
Synthesis
Diethylstilbestrol, trans-α,β-diethyl-4,4-stilbendiol (28.1.34), is proposed
to be synthesized in various ways. According to one of them, desoxyansoine is alkylated
by ethyl iodide in the presence of sodium ethoxide, and the resulting ketone (28.1.30)
is reacted in a Grignard reaction with ethylmagnesium bromide, which forms the carbinol
(28.1.31). Dehydration of this compound by distillation in the presence of p-toluenesulfonic
acid gives dimethyl ether of stilbestrol (28.1.32), methyl groups of which are
removed by heating it at high temperatures with potassium hydroxide, thus forming
diethylstilbestrol (28.1.33).
Check Digit Verification of cas no
The CAS Registry Mumber 6898-97-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,8,9 and 8 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 6898-97:
(6*6)+(5*8)+(4*9)+(3*8)+(2*9)+(1*7)=161
161 % 10 = 1
So 6898-97-1 is a valid CAS Registry Number.
InChI:InChI=1/C18H20O2/c1-3-17(13-5-9-15(19)10-6-13)18(4-2)14-7-11-16(20)12-8-14/h5-12,19-20H,3-4H2,1-2H3/b18-17-
6898-97-1Relevant articles and documents
Anti-proliferative activities of flavone-estradiol Stille-coupling adducts and of indanone-based compounds obtained by SnCl4/Zn-catalysed McMurry cross-coupling reactions
Pathe, Gulab Khushalrao,Konduru, Naveen K.,Parveen, Iram,Ahmed, Naseem
, p. 83512 - 83521 (2015/10/19)
We described the synthesis of flavone-estradiol adducts and indanophen based tamoxifen analogs using a novel SnCl4-Zn reagent via a McMurry cross-coupling reaction and their anti-proliferative evaluation against human cervical cancer cell lines (HeLa) and human breast cancer cell lines (MCF-7 and MDA-MB-231). A library of 32 tamoxifen analogs was synthesized using indanone and propiophenone derivatives and evaluated for anti-proliferative activities. Among them, compounds 3ac, 3ad, 3ae and 3ao exhibited better anti-proliferative potencies (IC50 2.13-3.81 μM) than the drug doxorubicin (IC50 50 2.85 ± 0.17 μM and 2.42 ± 0.23 μM; 3.64 ± 0.28 μM and 2.93 ± 0.14 μM) against breast cancer cells (MCF-7 and MDA-MB-231) respectively and IC50 2.17 ± 0.18 μM and 2.56 ± 0.32 μM against cervical cancer cells (HeLa) respectively than the standard drug. However, compounds 6ac, 6ae, 6af and 6ag showed moderate activity (IC50 10 μM). The structure-activity relationship analysis revealed that the optimal combination of side chains at the para-position of propiophenone and fluoro substituent on the indanone moiety enhanced the anti-proliferative activities of tamoxifen analogs.
Human insulin analogues
-
, (2008/06/13)
The present invention relates to novel human insulin analogues exhibiting a low ability to associate in solution, a method for the preparation of such insulin analogues, insulin preparations containing the human insulin analogues of the invention and a method of treating Diabetes Mellitus using these human insulin analogues.